Altaxel NOVA 260 mg Injection

Get a Price/Quote

MOQ : 25 Boxes

Altaxel NOVA 260 mg Injection Specification

Origin of Medicine
INDIA

Physical Form
Liquid

Recommended For
DOCTOR

Quantity
25 Pairs

Marketed By
Fresenius Kabi Oncology Limited

Brand Name
Altaxel NOVA

Prescription Required
Yes

Shelf Life
24 months

Pack Type
Vial

Color
Clear solution

Administration Route
IV only

Altaxel NOVA 260 mg Injection Trade Information

Minimum Order Quantity
25 Boxes

Delivery Time
1 Week

About Altaxel NOVA 260 mg Injection

Altaxel Nova 260 mg Injection is a vital therapeutic option in the fight against breast cancer, ovarian cancer, and non-small cell lung cancer (NSCLC), often used in conjunction with other chemotherapy agents to enhance treatment efficacy. This powerful injection functions by targeting and inhibiting the growth of cancer cells, effectively disrupting their ability to divide and proliferate. While Altaxel Nova can be a crucial component of cancer therapy, it is important for patients to be aware of potential side effects, which may include common reactions like nausea or fatigue. Healthcare providers will carefully monitor patients for any serious adverse effects, ensuring a tailored approach to cancer treatment. The combination of Altaxel Nova with other medications is determined based on individual patient needs, aiming for the best possible outcomes. This medication represents an important advancement in oncological care, offering hope to those battling aggressive forms of cancer. Always consult with a healthcare professional to understand the benefits and risks associated with Altaxel Nova. By prioritizing patient safety and effective cancer management, Altaxel Nova plays a significant role in modern oncology.

Precision Oncology Care

Altaxel NOVA 260 mg Injection ensures precise dosing for cancer therapy. Administered intravenously by healthcare professionals, it delivers reliable performance with a clear solution, supporting optimal patient outcomes when used as directed in clinical settings.

Reliable Quality and Origin

Manufactured in India by Fresenius Kabi Oncology Limited, Altaxel NOVA exemplifies stringent quality control. The product, available in liquid form and packed in vials, remains stable up to 24 months, making it a dependable choice for medical practitioners and distributors.

FAQ's of Altaxel NOVA 260 mg Injection:

Q: How should Altaxel NOVA 260 mg Injection be administered?

A: Altaxel NOVA 260 mg Injection is intended strictly for intravenous (IV) use and must be administered by a qualified healthcare provider in a clinical or hospital setting.

Q: What is the physical appearance and packaging type of Altaxel NOVA?

A: The injection is a clear liquid solution, supplied in a sterile vial for secure handling and ease of administration by medical professionals.

Q: When is Altaxel NOVA 260 mg Injection typically used?

A: This medication is used as prescribed by doctors, primarily for oncology purposes, and only after a thorough diagnosis and medical evaluation.

Q: Where is Altaxel NOVA 260 mg Injection produced and distributed?

A: Altaxel NOVA is produced in India by Fresenius Kabi Oncology Limited and is distributed, exported, supplied, and traded by authorized pharmaceutical partners across India.

Q: What is the shelf life of Altaxel NOVA 260 mg Injection?

A: The injection remains stable and effective for up to 24 months when stored as per the recommended guidelines.

Q: Who is qualified to use and administer Altaxel NOVA 260 mg Injection?

A: Only licensed doctors should prescribe and supervise the administration of this medication. It is not intended for self-use or over-the-counter purchase.

Q: What are the benefits of sourcing Altaxel NOVA from authorized distributors?

A: Ordering from official distributors, exporters, and wholesalers ensures product authenticity, proper handling, and adherence to regulatory standards, guaranteeing safety for patients and healthcare providers.

Tell us about your requirement